Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In …
Over the last 12 months, insiders at Humana Inc. have bought $200,066 and sold $0 worth of Humana Inc. stock.
On average, over the past 5 years, insiders at Humana Inc. have bought $1.01M and sold $82.15M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Mesquita Jorge S. (director) — $200,066.
The last purchase of 545 shares for transaction amount of $200,066 was made by Mesquita Jorge S. (director) on 2024‑02‑20.
2024-02-20 | director | 545 0.0005% | $367.09 | $200,066 | -5.92% | |||
2023-05-04 | Sale | Chief Financial Officer | 4,156 0.0033% | $526.28 | $2.19M | -12.37% | ||
2023-02-27 | Sale | President & CEO | 17,575 0.014% | $505.85 | $8.89M | -3.43% | ||
2023-02-27 | Sale | Chief Administrative Officer | 2,628 0.0021% | $510.30 | $1.34M | -3.43% | ||
2023-02-27 | Sale | Chief Legal Officer | 2,048 0.0016% | $507.97 | $1.04M | -3.43% | ||
2022-12-21 | Sale | director | 15,000 0.0118% | $501.72 | $7.53M | -2.36% | ||
2022-12-16 | Sale | Chief Administrative Officer | 635 0.0005% | $497.71 | $316,045 | -1.40% | ||
2022-12-12 | Sale | President & CEO | 7,000 0.0056% | $531.92 | $3.72M | -6.27% | ||
2022-11-03 | Sale | President & CEO | 9,000 0.0072% | $566.17 | $5.1M | -11.35% | ||
2022-11-03 | Sale | Chief Information Officer | 7,962 0.0064% | $565.95 | $4.51M | -11.35% | ||
2022-11-03 | Sale | Chief Legal Officer | 3,155 0.0025% | $565.27 | $1.78M | -11.35% | ||
2022-11-03 | Sale | Segment President, Retail | 22,570 0.0181% | $566.21 | $12.78M | -11.35% | ||
2022-11-03 | Sale | Seg Pres, Pharmacy Sol & CCAO | 11,157 0.0089% | $565.61 | $6.31M | -11.35% | ||
2022-11-03 | Sale | Chief Financial Officer | 5,623 0.0045% | $566.25 | $3.18M | -11.35% | ||
2022-09-20 | Sale | Chief Administrative Officer | 7,437 0.0059% | $505.51 | $3.76M | -0.55% | ||
2022-09-20 | Sale | Chief Legal Officer | 1,226 0.001% | $506.78 | $621,313 | -0.55% | ||
2022-05-03 | Sale | Chief Information Officer | 3,957 0.0031% | $434.19 | $1.72M | +14.46% | ||
2022-04-28 | Sale | Chief Administrative Officer | 3,477 0.0027% | $443.14 | $1.54M | +8.09% | ||
2022-04-28 | Sale | Seg Pres, Pharmacy Sol & CCAO | 3,210 0.0025% | $449.68 | $1.44M | +8.09% | ||
2021-11-05 | Sale | President & CEO | 50,006 0.039% | $454.70 | $22.74M | -0.25% |
Mesquita Jorge S. | director | 2578 0.0021% | $292.37 | 2 | 0 | +7.45% |
JONES DAVID A SR/KY | director | 699098 0.5806% | $292.37 | 2 | 5 | +42.4% |
JONES DAVID A JR/KY | director | 42028 0.0349% | $292.37 | 3 | 20 | +5.58% |
BLOEM JAMES H | Sr. VP, CFO & Treasurer | 21767 0.0181% | $292.37 | 1 | 9 | <0.0001% |
DAMELIO FRANK A | director | 20634 0.0171% | $292.37 | 2 | 0 | <0.0001% |
The Vanguard Group | $3.84B | 9.19 | 11.08M | -0.85% | -$32.9M | 0.07 | |
BlackRock | $3.73B | 8.93 | 10.76M | -0.72% | -$26.95M | 0.08 | |
State Street | $1.95B | 4.66 | 5.61M | -3.79% | -$76.86M | 0.08 | |
Wellington Management Company | $1.91B | 4.56 | 5.49M | +2.46% | +$45.73M | 0.32 | |
Fidelity Investments | $1.29B | 3.08 | 3.71M | -22.62% | -$375.81M | 0.09 |